Page last updated: 2024-08-24

bmy 25067 and Urinary Bladder Neoplasms

bmy 25067 has been researched along with Urinary Bladder Neoplasms in 5 studies

*Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER. [MeSH]

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emerson, EO; Gupta, V; Jani, JP; Singh, SV; Xu, BH; Zaren, HA1
Gupta, V; Singh, SV; Xu, BH1
Benson, PJ; Gupta, V; Hu, X; Pinto, T; Singh, S; Xia, H; Zaren, HA1
Au, JL; Yen, WC1
Bleicher, RJ; Gupta, V; Hu, X; Singh, SV; Srivastava, SK; Xia, H; Zaren, HA1

Other Studies

5 other study(ies) available for bmy 25067 and Urinary Bladder Neoplasms

ArticleYear
Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Cancer letters, 1995, Aug-16, Volume: 95, Issue:1-2

    Topics: Antineoplastic Agents; Cell Cycle; Drug Resistance; Glutathione; Glutathione Transferase; Humans; In Vitro Techniques; Mitomycin; Mitomycins; NAD(P)H Dehydrogenase (Quinone); NADPH-Ferrihemoprotein Reductase; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1995
Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
    British journal of cancer, 1994, Volume: 69, Issue:2

    Topics: DNA, Neoplasm; Drug Resistance; Humans; Lipid Peroxidation; Mitomycin; Mitomycins; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms

1994
Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
    Cancer research, 1996, Aug-01, Volume: 56, Issue:15

    Topics: Antineoplastic Agents, Alkylating; Biotransformation; Buthionine Sulfoximine; Cysteine; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Humans; Methionine Sulfoximine; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1996
Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.
    Pharmaceutical research, 1997, Volume: 14, Issue:2

    Topics: Administration, Intravesical; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Survival; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1997
Characterization of a BMS-181174-resistant human bladder cancer cell line.
    British journal of cancer, 1997, Volume: 76, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Cell Survival; Drug Resistance; Humans; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1997